Literature DB >> 17475822

A population-based, prospective study of blood pressure and risk for end-stage renal disease in China.

Kristi Reynolds1, Dongfeng Gu, Paul Muntner, John W Kusek, Jing Chen, Xigui Wu, Xiufang Duan, Chung-Shiuan Chen, Michael J Klag, Paul K Whelton, Jiang He.   

Abstract

The association between BP and risk for ESRD has not been well characterized in Asian populations. This study examined the relationship between level of BP and incidence of ESRD in a prospective cohort study of 158,365 Chinese men and women who were 40 yr and older. Measurement of BP and covariables were made in 1991 following a standard protocol. Follow-up evaluations were conducted in 1999 to 2000 and included interviewing participants or proxies and obtaining medical records and death certificates for ESRD cases. During 1,236,422 person-years of follow-up, 380 participants initiated renal replacement therapy or died from renal failure (30.7 cases per 100,000 person-years). Compared with those with normal BP, the multivariate adjusted hazard ratios (95% confidence interval) of all-cause ESRD for prehypertension and stage 1 and stage 2 hypertension were 1.30 (0.98 to 1.74), 1.47 (1.06 to 2.06), and 2.60 (1.89 to 3.57), respectively (P < 0.001 for trend). The corresponding hazard ratios (95% confidence interval) of glomerulonephritis-related ESRD were 1.32 (0.82 to 2.11), 1.48 (0.83 to 2.61), and 3.40 (2.02 to 5.74), respectively (P <0.001 for trend). Systolic BP was a stronger predictor of ESRD than diastolic BP or pulse pressure. This study provides novel data on the incidence of ESRD and on the association between BP and glomerulonephritis-related ESRD from a nationally representative sample of adults in China. These results document the importance of high BP as a modifiable risk factor for ESRD in China. Strategies to prevent ESRD should incorporate the prevention, treatment, and control of BP.

Entities:  

Mesh:

Year:  2007        PMID: 17475822     DOI: 10.1681/ASN.2006111199

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  30 in total

1.  Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk.

Authors:  Deborah L Feairheller; Kathleen M Sturgeon; Keith M Diaz; Praveen Veerabhadrappa; Sheara T Williamson; Deborah L Crabbe; Michael D Brown
Journal:  Kidney Blood Press Res       Date:  2010-07-13       Impact factor: 2.687

Review 2.  Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.

Authors:  Rikki M Tanner; Todd M Brown; Paul Muntner
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

3.  Risk factors for end-stage renal disease: 25-year follow-up.

Authors:  Chi-yuan Hsu; Carlos Iribarren; Charles E McCulloch; Jeanne Darbinian; Alan S Go
Journal:  Arch Intern Med       Date:  2009-02-23

4.  Comparison of the Framingham Heart Study hypertension model with blood pressure alone in the prediction of risk of hypertension: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Paul Muntner; Mark Woodward; Devin M Mann; Daichi Shimbo; Erin D Michos; Roger S Blumenthal; April P Carson; Haiying Chen; Donna K Arnett
Journal:  Hypertension       Date:  2010-05-03       Impact factor: 10.190

5.  Relationship between prehypertension and incidence of chronic kidney disease in a general population: a prospective analysis in central south China.

Authors:  Xia Cao; Xiumei Xie; Jiansong Zhou; Hong Yuan; Zhiheng Chen
Journal:  Int Urol Nephrol       Date:  2014-08-19       Impact factor: 2.370

6.  Hydrogen sulphide-related thiol metabolism and nutrigenetics in relation to hypertension in an elderly population.

Authors:  Mark Lucock; Zoë Yates; Charlotte Martin; Jeong-Hwa Choi; Lyndell Boyd; Sa Tang; Nenad Naumovski; Paul Roach; Martin Veysey
Journal:  Genes Nutr       Date:  2012-08-21       Impact factor: 5.523

7.  Uric acid-lowering and renoprotective effects of topiroxostat, a selective xanthine oxidoreductase inhibitor, in patients with diabetic nephropathy and hyperuricemia: a randomized, double-blind, placebo-controlled, parallel-group study (UPWARD study).

Authors:  Takashi Wada; Tatsuo Hosoya; Daisuke Honda; Ryusuke Sakamoto; Kazutaka Narita; Tomomitsu Sasaki; Daisuke Okui; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2018-01-25       Impact factor: 2.801

8.  Association of Longitudinal Trajectories of Systolic BP with Risk of Incident CKD: Results from the Korean Genome and Epidemiology Study.

Authors:  Young Su Joo; Changhyun Lee; Hyung Woo Kim; Jonghyun Jhee; Hae-Ryong Yun; Jung Tak Park; Tae Ik Chang; Tae-Hyun Yoo; Shin-Wook Kang; Seung Hyeok Han
Journal:  J Am Soc Nephrol       Date:  2020-08-05       Impact factor: 10.121

9.  Prehypertension during young adulthood and coronary calcium later in life.

Authors:  Mark J Pletcher; Kirsten Bibbins-Domingo; Cora E Lewis; Gina S Wei; Steve Sidney; J Jeffrey Carr; Eric Vittinghoff; Charles E McCulloch; Stephen B Hulley
Journal:  Ann Intern Med       Date:  2008-07-15       Impact factor: 25.391

10.  End-stage renal disease in young black males in a black-white population: longitudinal analysis of the Bogalusa Heart Study.

Authors:  Paul Muntner; Asghar Arshad; Stephen A Morse; Dharmendrakumar A Patel; Pronabesh D Manapatra; Efrain Reisin; Erwin A Aguilar; Wei Chen; Sathanur Srinivasan; Gerald S Berenson
Journal:  BMC Nephrol       Date:  2009-12-02       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.